Collectively, these data suggest that while nuclear activation of TFE family members has an oncogenic function in renal cancer generally, TFE3 oncofusion proteins are specifically required to mediate malignant transformation in tRCC. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.